BlackRock Health Sciences Trust (NYSE:BME) saw a significant decrease in short interest in March. As of March 31st, there was short interest totalling 5,200 shares, a decrease of 38.1% from the March 15th total of 8,400 shares. Based on an average daily volume of 35,400 shares, the short-interest ratio is presently 0.1 days.
A number of hedge funds have recently modified their holdings of BME. Chiron Capital Management LLC acquired a new position in BlackRock Health Sciences Trust during the third quarter worth approximately $33,000. Institutional & Family Asset Management LLC acquired a new position in BlackRock Health Sciences Trust during the fourth quarter worth approximately $66,000. M&T Bank Corp acquired a new position in BlackRock Health Sciences Trust during the fourth quarter worth approximately $203,000. SOA Wealth Advisors LLC. acquired a new stake in shares of BlackRock Health Sciences Trust in the fourth quarter worth $242,000. Finally, Eudaimonia Partners LLC increased its position in shares of BlackRock Health Sciences Trust by 54.1% in the third quarter. Eudaimonia Partners LLC now owns 7,975 shares of the company’s stock worth $342,000 after acquiring an additional 2,800 shares in the last quarter.
Shares of BME traded down $0.35 on Friday, hitting $48.80. 24,824 shares of the stock traded hands, compared to its average volume of 35,501. The stock’s 50 day moving average is $46.13 and its two-hundred day moving average is $46.42. BlackRock Health Sciences Trust has a 1 year low of $38.61 and a 1 year high of $50.94.
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Further Reading: Most Active Stocks
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.